Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1719900

registered interest
date	21/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgical Mesh Implants: Compensation
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Independent Medicines and Medical Devices Safety Review report First Do No Harm, published on 8 July 2020, what steps they will take to provide monetary compensation for people adversely affected by clinical and surgical pelvic mesh.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4823
answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.</p> answering member printed Lord Markham question first answered 24/05/2024 13:49:56 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717431

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory Syncytial Virus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they plan to generate real-world data on any future RSV immunisation programme for older adults and infants and, if so, how such data would be used to inform future eligibility.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4596
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The UK Health Security Agency monitors national immunisation programmes in England, and will monitor the implementation of any future protection immunisation programmes for older adults and infants. This includes immunisation coverage, immunisation effectiveness at preventing disease, including the duration of the protective effect, the overall impact of the immunisation programme, and any safety signals. This real-world data will be shared with the Joint Committee on Vaccination and Immunisation and the Department, to inform future policy including future eligibility.</p> answering member printed Lord Markham question first answered 23/05/2024 12:22:41 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717432

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory Syncytial Virus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to review eligibility for any future RSV immunisation programme, and whether such a review would be based on timing or on assessment of data.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4597
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Government have made a policy decision on the eligibility of a potential respiratory snncytial virus (RSV) programme, which is in line with the Joint Committee of Vaccination and Immunisation’s (JCVI) September 2023 advice.</p><p>When a new immunisation programme is introduced, policy decisions are made about who the National Health Service will offer the immunisation to. These decisions are based on the advice and recommendations of the JCVI. The eligibility of an immunisation programme is not reviewed in a time-based manner, although the JCVI keeps all immunisation programmes and advice under review and can update its advice based on new and emerging data.</p> answering member printed Lord Markham question first answered 23/05/2024 14:34:14 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717433

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to evaluate and understand the impact of immunisation programmes on productivity and economic outcomes.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4598
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Department continues to work across the health system, with the devolved administrations, to deliver robust, cost-effective programmes which benefit public health. The Joint Committee for Vaccination and Immunisation (JCVI) advises on the approach to immunisation, and also evaluates opportunities to deliver robust, cost-effective programmes that protect public health. Investments in vaccines and other health interventions are assessed for cost effectiveness within a broader framework that allows one intervention to be assessed fairly alongside another.</p><p>While the JCVI does not consider productivity and economic outcomes, the Department can still opt to consider the productivity and economic impacts of immunisation, where this is judged to be an important additional consideration, in line with His Majesty's Treasury’s Green Book guidance.</p> answering member printed Lord Markham grouped question UIN HL4599 question first answered 23/05/2024 12:01:06 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717434

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to work with NHS England and with the devolved administrations to ensure that socioeconomic benefits from immunisation, including those relating to productivity, can be fully realised in the UK.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4599
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Department continues to work across the health system, with the devolved administrations, to deliver robust, cost-effective programmes which benefit public health. The Joint Committee for Vaccination and Immunisation (JCVI) advises on the approach to immunisation, and also evaluates opportunities to deliver robust, cost-effective programmes that protect public health. Investments in vaccines and other health interventions are assessed for cost effectiveness within a broader framework that allows one intervention to be assessed fairly alongside another.</p><p>While the JCVI does not consider productivity and economic outcomes, the Department can still opt to consider the productivity and economic impacts of immunisation, where this is judged to be an important additional consideration, in line with His Majesty's Treasury’s Green Book guidance.</p> answering member printed Lord Markham grouped question UIN HL4598 question first answered 23/05/2024 12:01:06 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717435

registered interest
date	13/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Productivity
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to enable evaluation of health programmes and investments to account for productivity benefits, in line with guidance issued in the Green Book.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4600
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The Department has well-established policies and mechanisms in place to ensure health programmes and investments are subject to systematic evaluation at key stages in their lifecycle, in accordance with HM Treasury’s business case guidance. This includes reviewing quantitative and qualitative evidence on whether approved health projects achieve their objectives and deliver the promised benefits within the agreed budget, timescale, and scope. Lessons from post-project evaluation are widely disseminated, to support better investment decisions in future, and more robustly developed business cases.</p> answering member printed Lord Markham question first answered 20/05/2024 10:34:42 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717025

registered interest
date	09/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Staff
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the UK Radiotherapy Board report Recovering radiotherapy services in England: Our plan for action, published in May, what assessment they have made of the finding that "a relatively small increase in staff funding would make a big difference to patient care".
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4531
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Whilst no assessment has been made of this finding, the NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. It will put the workforce on a sustainable footing for the long term.</p><p>The Government is backing the LTWP with over £2.4 billion over the next five years, to fund additional education and training places. This is on top of increases to education and training investment, reaching a record total of £6.1 billion over the next two years. By significantly expanding domestic education, training, and recruitment, we will have more healthcare professionals working in the NHS. This will include more doctors and nurses, alongside an expansion in a range of other professions, including more staff working in new roles. The LTWP also commits to reform and modernise the way staff work, and harness new technology and innovations to increase productivity and make sure staff can spend more time with patients.</p><p>In January 2024 there were 35,252 full-time equivalent (FTE) staff in the cancer workforce, an increase of 60.7% since January 2010. This includes 8,142 FTE consultants in January 2024, an increase of 69.6% since January 2010. There are 3,144 FTE therapeutic radiographers working in NHS trusts and other core organisations in England. This is 4.3% more than in 2023, 14.6% more than in 2019, and 55.2% more than in 2010.</p> answering member printed Lord Markham question first answered 23/05/2024 12:05:44 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717026

registered interest
date	09/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Expenditure
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what was the total amount spent by the NHS on radiotherapy services in England in the past year, broken down by (1) region, and (2) NHS trust.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4532
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>Whilst data for the past year is not yet available, the latest published data on radiotherapy costs is from the National Health Service national cost collection for 2021/22, where spend is reported as £550 million. More detailed data by the NHS trusts is also available at the NHS website, in an online only format.</p> answering member printed Lord Markham question first answered 20/05/2024 15:05:30 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1717027

registered interest
date	09/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they plan to support NHS England’s pilot to reduce the faecal immunochemical test threshold for the Bowel Cancer Screening Programme from 120µg/g to 80µg/g; and whether they have had discussions with NHS England regarding geographical areas for the pilot.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4533
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>We are committed to improving the NHS Bowel Screening programme, and welcome NHS England’s plans for pilot areas, which will reduce the faecal immunochemical test (FIT) down to 80µg/g. NHS England plans to publish an Expression of Interest to give all bowel screening services, and their partner symptomatic endoscopy providers, an opportunity to submit their interest in becoming a FIT@80 pilot site. These pilot sites are planned to be selected and launched later in 2024/25, and attention will be paid to ensure there is regional variation across the pilot sites selected.</p> answering member printed Lord Markham question first answered 20/05/2024 15:13:03 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1716662

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made towards ensuring that people with cancer who require radiotherapy treatment can start treatment within their target of 31 days.
tabling member printed	Baroness Ritchie of Downpatrick
uin	HL4473
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>We are seeing continued high levels of urgent cancer referrals, with over 12,000 urgent referrals seen for suspected cancer per working day in March 2024, compared to approximately 9,000 in March 2019. In March 2023, 89.7% of patients received a first or subsequent radiotherapy treatment within 31 days of a decision to treat, which is 0.6% higher than last year. From March 2023/24, 127,336 people received a first or subsequent radiotherapy treatment, which is 1,359 more than the previous year.</p><p>The Government continues to work with NHS England on implementing the Delivery plan for tackling the COVID-19 backlog of elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.</p><p>We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. This includes over 8,100 FTE consultants in January 2024, an increase of over 3,300, or 69.6% since January 2010.</p><p>Since 2016, the Department has invested £162 million into cutting-edge radiotherapy equipment to replace or upgrade more than 100 radiotherapy treatment machines, so we can deliver the best possible outcomes for patients. From April 2022, the responsibility for investing in new radiotherapy machines sits with local systems.</p> answering member printed Lord Markham question first answered 20/05/2024 14:54:55 answering member 4948 label Biography information for Lord Markham
tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick